Monogram Technologies Inc (MGRM) - Multiplikator forward rega marang pendapatan
How does the diversification of Monogram Technologies (MGRM) robot components impact margins? This chart on GURU.Markets displays the trend via a forward P/S indicator, where 299.60 represents the current metric value. Specialized rigging delivery ensures system reliability. Meanwhile, independence from macroeconomic factors and the demand for innovation transform the asset into a defensive tool.
Monogram Orthopedics Inc. - rincian analitis lan metrik utama (MGRM)
- rega pasar lan target rega analis:
- indikator kapitalisasi pasar:
- rincian valuasi buku bisnis:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Monogram Technologies|MGRM - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Monogram Technologies|MGRM - Tanggungan utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Monogram Orthopedics Inc.|MGRM - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Monogram Orthopedics|Likuiditas cepet monogramorthopedics.com
- data bathi bisnis lan rasio investasi:
MGRM - Penghasilan resik perusahaan|Bathi sing dikarepake Monogram Technologies|MGRM - Pangali rega marang bathi|Rega marang bathi mangsa ngarep Monogram Technologies Inc|MGRM - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA Monogram Orthopedics Inc.|MGRM - Bathi operasional sadurunge potongan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Monogram Orthopedics|MGRM - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan monogramorthopedics.com|MGRM - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Monogram Technologies
- data dodolan lan asil:
Analisis umum perusahaan:MGRM (Monogram Orthopedics)
The forward P/S ratio compares the current market value of Monogram Technologies (MGRM) with expected revenue for the coming year, allowing for an assessment of the premium paid for future growth. This forward P/S indicator demonstrates the company's ability to scale sales of robotic orthopedic systems and pass costs onto clinics, helping investors distinguish an undervalued asset from a value trap during periods of stagnation.
Analisis perusahaan pesaing
Rasio rega marang prakiraan pendapatan Intuitive ISRG|Rega forward marang dodolan DHR|BDX: Multiplikator forward rega marang pendapatan|STE - Multiplikator Forward P/S|West Pharmaceutical Services (WST) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan baxter.com|MASI (Masimo) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Stevanato Group SpA STVN|Rasio rega marang prakiraan pendapatan Teleflex Inc (TFX)|Merit Medical Corp - Kapitalisasi marang prakiraan pendapatan|Envista Holdings - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ICUI (icumed.com)|XRAY - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake LeMaitre Vascular Inc LMAT|AtriCure Corp (ATRC) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan STAAR Surgical Co|Rasio rega marang prakiraan pendapatan ChromaDex Corporation|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep zimvie.com ZIMV|Rasio rega marang prakiraan pendapatan AngioDynamics (ANGO)|Cerus Corp. - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Alpha Teknova Inc TKNO|Sharps Technology Inc (STSS) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|InfuSystem Inc - Multiplikator Forward P/S|Prakiraan rega marang pendapatan utahmed.com (UTMD)|korumedical.com (KRMD) - Rasio rega marang prakiraan pendapatan|Nyxoah SA - Rega forward marang dodolan|MBOT (Microbot Medical Inc) - Multiplikator Forward P/S|Multiplikator Forward P/S Pro-Dex Inc.|Rasio rega marang prakiraan pendapatan Zentek Ltd. (ZTEK)|Multiplikator forward rega marang pendapatan elutia.com ELUT|Milestone Scientific Inc. - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan NXGL|RVP: Multiplikator forward rega marang pendapatan|harvardbioscience.com - Rasio rega marang pendapatan sing dikarepake|FEMY: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Meihua Medical Technologies Co., Ltd. (MHUA)|POAI (Predictive Oncology Inc) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Callan JMB Corp (CJMB)|Multiplikator Forward P/S ATRI|NURO (NeuroMetrix Corporation) - Rega forward marang dodolan
